Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000089

Director acquired 2,023 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-01 Grant or award : show line 1 in the form +2,023 $5.56 $11,248 116,694 D
Loading xslF345X05/wk-form4_1727901140.xml…